Jasmeet Singh Khara

760 total citations
16 papers, 630 citations indexed

About

Jasmeet Singh Khara is a scholar working on Microbiology, Immunology and Molecular Biology. According to data from OpenAlex, Jasmeet Singh Khara has authored 16 papers receiving a total of 630 indexed citations (citations by other indexed papers that have themselves been cited), including 9 papers in Microbiology, 6 papers in Immunology and 5 papers in Molecular Biology. Recurrent topics in Jasmeet Singh Khara's work include Antimicrobial Peptides and Activities (9 papers), Chemical Synthesis and Analysis (4 papers) and Invertebrate Immune Response Mechanisms (4 papers). Jasmeet Singh Khara is often cited by papers focused on Antimicrobial Peptides and Activities (9 papers), Chemical Synthesis and Analysis (4 papers) and Invertebrate Immune Response Mechanisms (4 papers). Jasmeet Singh Khara collaborates with scholars based in Singapore, United Kingdom and Australia. Jasmeet Singh Khara's co-authors include Pui Lai Rachel Ee, Ying Wang, Yi Yan Yang, Paul R. Langford, Sandra M. Newton, Xiyu Ke, Sybil Obuobi, Brian D. Robertson, Shaoqiong Liu and Melissa Shea Hamilton and has published in prestigious journals such as Biomaterials, Journal of Controlled Release and Frontiers in Immunology.

In The Last Decade

Jasmeet Singh Khara

14 papers receiving 628 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Jasmeet Singh Khara Singapore 13 332 320 115 95 80 16 630
Mohamed F. Mohamed United States 12 478 1.4× 494 1.5× 125 1.1× 99 1.0× 47 0.6× 19 825
Chenhong Zhu China 5 590 1.8× 536 1.7× 89 0.8× 117 1.2× 71 0.9× 11 942
Fazren Azmi Malaysia 12 131 0.4× 309 1.0× 106 0.9× 164 1.7× 81 1.0× 27 658
Natalia Molchanova Denmark 13 653 2.0× 669 2.1× 211 1.8× 82 0.9× 60 0.8× 23 1.0k
A. El Ghalbzouri Netherlands 6 355 1.1× 344 1.1× 101 0.9× 56 0.6× 35 0.4× 8 679
Anselmo J. Otero‐González Cuba 17 344 1.0× 382 1.2× 102 0.9× 65 0.7× 73 0.9× 31 694
Esteban Nicolás Lorenzón Brazil 18 423 1.3× 441 1.4× 101 0.9× 59 0.6× 106 1.3× 32 829
Jayaram Lakshmaiah Narayana United States 14 645 1.9× 525 1.6× 86 0.7× 175 1.8× 63 0.8× 20 844
Gisele Rodrigues Brazil 12 273 0.8× 298 0.9× 51 0.4× 54 0.6× 51 0.6× 20 596
Jun Lei China 7 590 1.8× 545 1.7× 85 0.7× 115 1.2× 34 0.4× 17 958

Countries citing papers authored by Jasmeet Singh Khara

Since Specialization
Citations

This map shows the geographic impact of Jasmeet Singh Khara's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jasmeet Singh Khara with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jasmeet Singh Khara more than expected).

Fields of papers citing papers by Jasmeet Singh Khara

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Jasmeet Singh Khara. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jasmeet Singh Khara. The network helps show where Jasmeet Singh Khara may publish in the future.

Co-authorship network of co-authors of Jasmeet Singh Khara

This figure shows the co-authorship network connecting the top 25 collaborators of Jasmeet Singh Khara. A scholar is included among the top collaborators of Jasmeet Singh Khara based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Jasmeet Singh Khara. Jasmeet Singh Khara is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

16 of 16 papers shown
1.
Chee, Cheng Ean, et al.. (2024). Cost-effectiveness analysis of atezolizumab plus bevacizumab compared with sorafenib as first-line treatment in advanced hepatocellular carcinoma in Singapore. Expert Review of Pharmacoeconomics & Outcomes Research. 24(5). 631–641.
2.
Khara, Jasmeet Singh, Biljana Mojsoska, Devika Mukherjee, et al.. (2020). Ultra-Short Antimicrobial Peptoids Show Propensity for Membrane Activity Against Multi-Drug Resistant Mycobacterium tuberculosis. Frontiers in Microbiology. 11. 417–417. 26 indexed citations
3.
Obuobi, Sybil, et al.. (2019). Facile and efficient encapsulation of antimicrobial peptides via crosslinked DNA nanostructures and their application in wound therapy. Journal of Controlled Release. 313. 120–130. 81 indexed citations
4.
Asai, Masanori, Yan-Wen Li, Jasmeet Singh Khara, et al.. (2019). Galleria mellonella: An Infection Model for Screening Compounds Against the Mycobacterium tuberculosis Complex. Frontiers in Microbiology. 10. 2630–2630. 21 indexed citations
5.
Asai, Masanori, Yan-Wen Li, Jasmeet Singh Khara, et al.. (2019). Use of the Invertebrate <em>Galleria mellonella</em> as an Infection Model to Study the <em>Mycobacterium tuberculosis</em> Complex. Journal of Visualized Experiments.
6.
Asai, Masanori, Yan-Wen Li, Jasmeet Singh Khara, et al.. (2019). Use of the Invertebrate <em>Galleria mellonella</em> as an Infection Model to Study the <em>Mycobacterium tuberculosis</em> Complex. Journal of Visualized Experiments. 7 indexed citations
7.
Obuobi, Sybil, et al.. (2018). Antimicrobial and Anti‐Biofilm Activities of Surface Engineered Polycationic Albumin Nanoparticles with Reduced Hemolytic Activity. Macromolecular Bioscience. 18(10). e1800196–e1800196. 13 indexed citations
8.
Li, Yan-Wen, John Spiropoulos, William Cooley, et al.. (2018). Galleria mellonella - a novel infection model for the Mycobacterium tuberculosis complex. Virulence. 9(1). 1126–1137. 28 indexed citations
9.
Khara, Jasmeet Singh, Sybil Obuobi, Ying Wang, et al.. (2017). Disruption of drug-resistant biofilms using de novo designed short α-helical antimicrobial peptides with idealized facial amphiphilicity. Acta Biomaterialia. 57. 103–114. 85 indexed citations
10.
Wang, Ying, Xiyu Ke, Zhi Xiang Voo, et al.. (2016). Biodegradable functional polycarbonate micelles for controlled release of amphotericin B. Acta Biomaterialia. 46. 211–220. 66 indexed citations
11.
Khara, Jasmeet Singh, Iria Uhía, Melissa Shea Hamilton, et al.. (2016). Unnatural amino acid analogues of membrane-active helical peptides with anti-mycobacterial activity and improved stability. Journal of Antimicrobial Chemotherapy. 71(8). 2181–2191. 53 indexed citations
12.
Battersby, Anna, Jasmeet Singh Khara, Victoria Wright, Ofer Levy, & Beate Kampmann. (2016). Antimicrobial Proteins and Peptides in Early Life: Ontogeny and Translational Opportunities. Frontiers in Immunology. 7. 309–309. 42 indexed citations
13.
Wang, Ying, Amgad R. Rezk, Jasmeet Singh Khara, Leslie Y. Yeo, & Pui Lai Rachel Ee. (2016). Stability and efficacy of synthetic cationic antimicrobial peptides nebulized using high frequency acoustic waves. Biomicrofluidics. 10(3). 34115–34115. 22 indexed citations
14.
Khara, Jasmeet Singh, Ying Wang, Xiyu Ke, et al.. (2015). Designing α-helical peptides with enhanced synergism and selectivity against Mycobacterium smegmatis: Discerning the role of hydrophobicity and helicity. Acta Biomaterialia. 28. 99–108. 66 indexed citations
15.
Wang, Ying, Xiyu Ke, Jasmeet Singh Khara, et al.. (2014). Synthetic modifications of the immunomodulating peptide thymopentin to confer anti-mycobacterial activity. Biomaterials. 35(9). 3102–3109. 19 indexed citations
16.
Khara, Jasmeet Singh, Ying Wang, Xiyu Ke, et al.. (2013). Anti-mycobacterial activities of synthetic cationic α-helical peptides and their synergism with rifampicin. Biomaterials. 35(6). 2032–2038. 101 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026